Author(s): MartinnTorres F, Bouzn Alejandro M, Redondo Collazo L, Snchez Lastres JM, Prtega Daz S,
Abstract Share this page
Abstract With the aim of determining rotavirus vaccine effectiveness (RVVE) in Spain, from Oct-2008/Jun-2009, 467 consecutive children below 2 years old with acute gastroenteritis (AGE) were recruited using a pediatric research network (ReGALIP-www.regalip.org) that includes primary, emergency and hospital care settings. Of 467 enrolled children, 32.3\% were rotavirus positive and 35.0\% had received at least one dose of any rotavirus vaccine. RRVE to prevent any episode of rotavirus AGE was 91.5\% (95\% CI: 83.7\%-95.6\%). RVVE to prevent hospitalization by rotavirus AGE was 95.6\% (85.6-98.6\%). No differences in RVVE were found regarding the vaccine used. Rotavirus vaccines have showed an outstanding effectiveness in Spain.
This article was published in Hum Vaccin
and referenced in Journal of Vaccines & Vaccination